Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-25T21:03:20.183Z Has data issue: false hasContentIssue false
  • English
  • Français

Paresthesias and Weakness of Lower Limbs as Symptomatic Debut of Lhermitte–Duclos Disease

Published online by Cambridge University Press:  12 May 2022

Lorenzo Ismael Pérez-Sánchez Open the ORCID record for Lorenzo Ismael Pérez-Sánchez [Opens in a new window]  and
Juan-Jesús Gómez-Herrera
Lorenzo Ismael Pérez-Sánchez*
Affiliation:
Department of Radiology, General Hospital of Segovia, C/ Luis Erik Clavería Neurólogo s/n, 40002 Segovia, Spain
Juan-Jesús Gómez-Herrera
Affiliation:
Department of Radiology, Hospital Nuestra Señora del Prado, CTRA. MADRID-EXTREMADURA, KM, 45600 Talavera de la Reina, Toledo, Spain
*
Corresponding author: Lorenzo Ismael Pérez-Sánchez, Department of Radiology, General Hospital of Segovia, C/ Luis Erik Clavería Neurólogo s/n, 40002 Segovia, Spain. Email: lorenzoips@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Lhermitte–Duclos diseaseHamartoma syndromeMultipleCowden syndromeMagnetic resonance imagingEndoscopy
Type
Neuroimaging Highlight
Information
Canadian Journal of Neurological Sciences , Volume 50 , Issue 3 , May 2023 , pp. 435 - 437
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Louis, DN, Perry, A, Wesseling, P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231–51. DOI 10.1093/neuonc/noab106.CrossRefGoogle ScholarPubMed
Abel, TW, Baker, SJ, Fraser, MM, et al. Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol. 2005;64:341–9. DOI 10.1093/jnen/64.4.341.CrossRefGoogle ScholarPubMed
Pilarski, R, Burt, R, Kohlman, W, Pho, L, Shannon, KM, Swisher, E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013;105:1607–16. DOI 10.1093/jnci/djt277.CrossRefGoogle ScholarPubMed
Zhang, HW, Zhang, YQ, Liu, XL, et al. MR imaging features of Lhermitte-Duclos disease: case reports and literature review. Medicine (Baltimore). 2022;101:e28667. DOI 10.1097/MD.0000000000028667.CrossRefGoogle ScholarPubMed
Huang, S, Zhang, G, Zhang, J. Similar MR imaging characteristics but different pathological changes: a misdiagnosis for Lhermitte-Duclos disease and review of the literature. Int J Clin Exp Pathol. 2015;8:7583–7.Google ScholarPubMed
Ma, J, Jia, G, Chen, S, Jia, W. Clinical perspective on dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos disease). World Neurosurg. 2019;122:16–23. DOI 10.1016/j.wneu.2018.10.085.CrossRefGoogle ScholarPubMed
Agarwal, R, Liebe, S, Turski, ML, Pan-Cancer Working Group. Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome. Discov Med. 2015;19:109–16.Google ScholarPubMed
Hendricks, LAJ, Hoogerbrugge, N, Schuurs-Hoeijmakers, JHM, Vos, JR. A review on age-related cancer risks in PTEN hamartoma tumor syndrome. Clin Genet. 2021;99:219–25. DOI 10.1111/cge.13875.CrossRefGoogle ScholarPubMed